President Donald J. Trump announced the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for convalescent plasma as a therapeutic treatment in COVID patients Sunday.
Convalescent plasma is the liquid part of the blood that contains COVID antibodies. Convalescent plasma given to COVID patients during research conducted since April by the Mayo Clinic has resulted in a 35% decrease in the incidence of death in the patients receiving the plasma, according to FDA Director Stephen Hahn.
The announcement is significant in Ohio where Republican Governor Mike DeWine has hinted for months at his hesitation to allow Ohioans to return to normal life until there is a vaccine. Read More
Governor Walz lifted the restrictions on access to hydroxychloroquine, a drug that has been in use for decades to treat a wide variety of illnesses – including SARS-type infections – that some say may be an effective therapeutic for COVID-19. The removal of limitations on the drug were outlined in Walz’s latest executive order issued last week.
Walz did not give an explanation for the reversal of his order on the drug. Read More
President Donald Trump casually let slip Monday afternoon that he’s been taking hydroxychloroquine, the anti-malarial drug he’s touted as a promising treatment for Covid-19 patients that has become a lightning rod for controversy.
“A couple of weeks ago, I started taking it,” Trump told reporters during a roundtable at the White House with restaurant executives and industry leaders.
“I was just waiting to see your eyes light up when I said this,” Trump added. Read More